GKB
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Gkb Ophthalmics Approves Unsecured Loan Of Upto 50 Mln Rupees
Jan 3 (Reuters) - GKB Ophthalmics Ltd GKBO.BO:
APPROVES UNSECURED LOAN OF UPTO 50 MILLION RUPEES
Source text: ID:nBSE3Qdp19
Further company coverage: GKBO.BO
(([email protected];;))
Jan 3 (Reuters) - GKB Ophthalmics Ltd GKBO.BO:
APPROVES UNSECURED LOAN OF UPTO 50 MILLION RUPEES
Source text: ID:nBSE3Qdp19
Further company coverage: GKBO.BO
(([email protected];;))
Upcoming Events:
Quarterly Results
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does GKB Ophthalmics do?
Established in 1981, GKB Ophthalmics is a public listed company specialized in manufacturing single vision, bifocal, and progressive lenses for export to global markets.
Who are the competitors of GKB Ophthalmics?
GKB Ophthalmics major competitors are Galaxy Medicare, Centenial Surgical, Amkay Products, KMS Medisurgi, Transpact Enterprise, Laser Eyecare, Kretto Syscon. Market Cap of GKB Ophthalmics is ₹34 Crs. While the median market cap of its peers are ₹39 Crs.
Is GKB Ophthalmics financially stable compared to its competitors?
GKB Ophthalmics seems to be less financially stable compared to its competitors. Altman Z score of GKB Ophthalmics is 1.77 and is ranked 5 out of its 8 competitors.
Does GKB Ophthalmics pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. GKB Ophthalmics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has GKB Ophthalmics allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances
How strong is GKB Ophthalmics balance sheet?
GKB Ophthalmics balance sheet is weak and might have solvency issues
Is the profitablity of GKB Ophthalmics improving?
No, profit is decreasing. The profit of GKB Ophthalmics is -₹7.85 Crs for TTM, -₹7.04 Crs for Mar 2025 and -₹2.81 Crs for Mar 2024.
Is the debt of GKB Ophthalmics increasing or decreasing?
Yes, The net debt of GKB Ophthalmics is increasing. Latest net debt of GKB Ophthalmics is -₹13.09 Crs as of Mar-25. This is greater than Mar-24 when it was -₹24.13 Crs.
Is GKB Ophthalmics stock expensive?
GKB Ophthalmics is not expensive. Latest PE of GKB Ophthalmics is 0.0, while 3 year average PE is 11.3. Also latest EV/EBITDA of GKB Ophthalmics is 0.0 while 3yr average is 66.09.
Has the share price of GKB Ophthalmics grown faster than its competition?
GKB Ophthalmics has given lower returns compared to its competitors. GKB Ophthalmics has grown at ~-34.81% over the last 1yrs while peers have grown at a median rate of -8.0%
Is the promoter bullish about GKB Ophthalmics?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in GKB Ophthalmics is 51.06% and last quarter promoter holding is 51.06%.
Are mutual funds buying/selling GKB Ophthalmics?
There is Insufficient data to gauge this.
